The Center for Applied Proteomics and Molecular Medicine was founded and is co-directed by Lance Liotta, former Chief of the Laboratory of Pathology at the National Cancer Institute and Emanuel Petricoin, formerly the senior investigator in the Office of Cell Tissue and Gene Therapies in the Center for Biologics Evaluation and Research at the FDA. Both scientists had previously co-directed the National Cancer Institute/Food and Drug Administration Clinical Proteomics Program

The pending CAP/CLIA laboratory puts the proteomic tools and theories into a hospital diagnostics facility to use directly in the treatment of patients. This lab is currently under construction and will partner with Perkin Elmer Life Sciences to demonstrate CAPMM technology in a clinical setting.